Table 1 Demographic and clinical characteristics of patients with psoriatic arthritis
PsA patients | |
|---|---|
Patient N | 67 |
Age, year | 57.0 (53.0, 63.0) |
Female (%) | 30 (44.8%) |
Disease duration, year | 21.0 (16.0, 28.0) |
CRP, mg/L | 1.9 (0.8, 4.9) |
ESR, mm/h | 24 (14, 41) |
DAPSA | 10.13 ± 6.55 |
DAPSA category | |
Remission | 14 (20.9%) |
Low disease activity | 33 (49.3%) |
Moderate disease activity | 18 (26.9%) |
High disease activity | 2 (3.0%) |
HAQ | 0.25 (0.00, 0.88) |
Tender joint count | 0 (0, 2) |
Swollen joint count | 0 (0, 1) |
Damage joint count | 4 (2, 10) |
Current treatment | |
csDMARDs (%) | 56 (83.6%) |
bDMARDs (%) | 27 (40.3%) |